Antidepressants are hypothesized to treat mental illness via immunoregulatory pathways, by decreasing levels of pro-inflammatory cytokines such as TNF52, IL-6, IL-1β, and IL-10 [43,45]. This evidence concerns the gene IL1B and psychiatric disorder.